Vivian Salama, Assistant Professor at WVU Cancer Institute, shared on LinkedIn:
“I am thrilled to share that our real-world Cardiovascular morbidity paper in Appalachian lung cancer population has been published at ‘Cancers; The State of The Art in CardioOncology.’
Our unique Appalachian cancer population are characterized by specific clinical, comorbidities and genetic features which make them different and unique.
They should not be treated as usual other populations. They need specific care.
You can’t come and tell me to use your ML models trained on other populations and let me use your models in our clinics.
Because the unique features of our population makes your models insufficient.
Please consider our population in your studies.
If you are interested in collaboration with us and sharing our unique population features, please contact me. Happy to discuss future collaborations opportunities.
Special thanks the WVUCI and its great leaders. Special thanks to the Radiation Oncology Department at WVU leaded by Dr. David Clump. Special thanks to my supervisor and colleague Dr. Phillip Pifer.
Thanks to my trainees Joseph Schmidlen and other medical students. Thanks to all our collaborators.”
Title: Cardiovascular Morbidity Following Definitive Chemoradiotherapy for Lung Cancer in an Appalachian Population
Authors: Vivian Salama, Joseph A. Schmidlen, John Christopher Knoth, Troy Nguyen, Aaron Naveen Joseph, Matthew Trotta, Ramon Alfredo Siochi, Raymond R. Raylman, Jeffrey Ryckman, Mohammed Almubarak, Christopher M. Bianco, David A. Clump, Mina F. Hanna, Phillip M. Pifer
Other articles about lung cancer and cardio-oncology on OncoDaily.